Mark Shilkrut

Publishing 2018

Is this you? Claim this profile
1
Article
461
Reads on Journament
22
Co-authors
1
Journal

This page collects the articles indexed under the name Mark Shilkrut. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected V600-Mutant Stage III Melanoma.
    Axel Hauschild, Reinhard Dummer, Dirk Schadendorf, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon, Caroline Robert and 11 more
    journal of clinical oncology : official journal of the american society of clinical oncology 2018 461 reads Novartis (Switzerland)

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Institutions on these papers

  • Novartis (Switzerland) · CH 1

From OpenAlex, for papers with a DOI.

Frequent co-authors

Publishes in